News search

E.g., 03/09/2025
E.g., 03/09/2025
Pablo García-Pavía, Nerea Mora Ayestarán y Fernando Domínguez
Research
3 Sep 2025

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), together with cardiologists from Hospital Universitario Puerta de Hierro and the Spanish cardiovascular disease research network (CIBERCV), report that the new discovery makes it possible to identify high-risk patients early and refer them sooner to specialized heart failure units

Valentín Fuster
About the CNIC
31 Aug 2025

From August 29 to September 1, Madrid hosts the European Society of Cardiology Congress (ESC Congress) and the World Heart Federation World Congress of Cardiology

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
Research
30 Aug 2025

REBOOT trial, coordinated by the CNIC, shows that treatment with beta-blockers provides no benefit to patients who experience an uncomplicated heart attack that leaves the contractile function of the heart intact.

ESC Congress 2025
About the CNIC
30 Aug 2025

The REBOOT study was presented during the European Society of Cardiology Congress (ESC Congress 2025) in Madrid

image
Research
16 Jul 2025

A new study led by the CNIC has identified imidazole propionate (ImP), a metabolite produced by gut bacteria, as a driver of atherosclerosis— as a driver of atherosclerosis, the disease behind most heart attacks and strokes

Sarai Martínez Cano, Marcos Femenía Muiña, Elena Hernández, Vanessa Núñez, Manuel Rodrigo Tapias, Miguel Galán Burgos, Iñaki Robles,  Alberto Benguria, David Sancho y Almudena Ramiro
Research
2 Jun 2025

A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models.

Jorge Nicolás Domínguez, Susana Temiño, Morena Raiola, Miquel Sendra y Miguel Torres.
Research
29 May 2025

CNIC researchers have discovered that the heart is formed from two independent cell types that act in synchrony from the onset of gastrulation. This finding could help to better understand the origin of certain congenital heart defects and open up new opportunities in regenerative medicine and tissue bioengineering.

Dr. Mariell Jessup
Research
14 May 2025

Dr. Mariell Jessup is Chief Science and Medical Officer of the American Heart Association

Juan Pablo Ochoa, Pablo García-Pavía, Laura Lalaguna, Marina López-Olañeta, María Arévalo-Núñez de Arenas y Enrique Lara-Pezzi.
Research
9 Apr 2025

A CNIC team has developed an innovative gene therapy strategy for arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly inherited condition that particularly affects young men

Enrique Lara-Pezzi, Laura Lalaguna, Benedetta Coppe, Nadia Mercader y María  Galardi-Castilla.
Research
2 Apr 2025

Scientists at the CNIC and the University of Bern have found that heart surgery in male mice early in life creates a "memory" passed down to the next generation. Published in Circulation, the study suggests that a parental history of heart surgery should be considered when evaluating cardiovascular health in descendants.